Fruquintinib
2024-415
Phase 2 small_molecule active
Quick answer
Fruquintinib for Colorectal Cancer Metastatic is a Phase 2 program (small_molecule) at Dai, Guanghai with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Dai, Guanghai
- Indication
- Colorectal Cancer Metastatic
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active